Evidence map›Paper›PMID 35536003›Full record

ArticlemBio2022

Harmonizing Prokaryotic Nomenclature: Fixing the Fuss over Phylum Name Flipping.

Adyasha Panda, Salim T Islam, Gaurav Sharma

Abstract read
In one paragraph

Article in mBio, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Review
  2. Article
  3. Creating a consensus genome assembly ofNAR genomics and bioinformatics · 2025
    Article
  4. Review
  5. The impact of ibezapolstat and otherAntimicrobial agents and chemotherapy · 2025
    Article
  6. Article
  7. Article
  8. WhiB-like proteins: Diversity of structure, function and mechanism.Biochimica et biophysica acta. Molecular cell research · 2024
    Review
  9. The dynamic history of prokaryotic phyla: discovery, diversity and division.International journal of systematic and evolutionary microbiology · 2024
    Review
  10. Review
  11. Article
  12. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Adyasha PandaInstitute of Bioinformatics and Applied Biotechnologygrid.418831.7 (IBAB), Bengaluru, Karnataka, India.
Salim T IslamInstitut National de la Recherche Scientifique (INRS), Centre Armand-Frappier Santé Biotechnologie, Université du Québec, Institut Pasteur International Network, Laval, Quebec, Canada.ORCID 0000-0001-6853-8446
Gaurav SharmaInstitute of Bioinformatics and Applied Biotechnologygrid.418831.7 (IBAB), Bengaluru, Karnataka, India.ORCID 0000-0002-2861-7446

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lloyd and Tahon recently criticized proposed bacterial phylum nomenclature changes (K.G. Lloyd, G. Tahon, Nat Rev Microbiol 20:123-124, 2022, https://doi.org/10.1038/s41579-022-00684-2) precipitated by the International Committee on Systematics of Prokaryotes (ICSP)'s official recognition of phylum nomenclature rules. Here, we extend the critique. While we applaud bringing consistency to phylum names, we prognosticate what this minute but momentous change entails for the future of microbial nomenclature and how this will sow confusion among researchers. Several pitfalls of the proposed ICSP framework-based nomenclature are also detailed, including (i) improper type genus name and suffix usage, (ii) loss of Bacteria/Archaea distinctions, (iii) disruption of major phylum name prefixes, and (iv) absence of organism name prevalidation. Finally, we suggest new names for the key bacterial phyla Proteobacteria (

Indexed as

ActinobacteriaEuryarchaeotaAnimalsArchaeaBacteriaFemaleProkaryotic CellsSwineArchaeaBacteriaclassificationInternational Code of Nomenclature of Prokaryotes (ICNP)nomenclaturepolyphasic taxonomysystematicstaxonomy

Identifiers

PMID35536003
PMCPMC9239268

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.